pharma · No medical condition. · Generalized Myasthenia Gravis
Anaxis Pharma
Lacuna Pharma Pty Ltd
Anaxis Pharma trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- Melbourne, AU
- Founded
- 2017
- Employees
- 7
- Programs
- 10
- Drugs
- 582
- Patents
- 0
Anaxis Pharma clinical trials
Registry index of 10 ClinicalTrials.gov studies linked to Anaxis Pharma programs — each row shows trial ID, program name, phase, status, and indication.
Anaxis Pharma trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Anaxis Pharma.
-
CRN00808-08 — Phase 3
Clinical update -
CRN00808-09 — Phase 3
Clinical update -
CAN-201 NDG — Phase 2
Clinical update -
EP-005 — Phase 2
Clinical update -
Paltusotine tablets, Paltusotine tablets — Phase 2
Clinical update -
SNOXA12C401 — Phase 2
Clinical update -
DBP-053-01 — Phase 1
Clinical update -
LY03010/CT-EUR-102 — Phase 1
Clinical update